Stanford Medicine researchers and collaborators have produced an intranasal liposomal vaccine that protected mice against ...

An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory ...

Researchers in Korea have reported that butyrate from commensal gut bacteria can enhance T follicular helper cell function, ...

32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics Series A expected to advance lead asset Mucosal-Immune Modulator CS-0003 through ...

Butyrate enhances Tfh cell function, promoting B cell–driven IgA antibody production and strengthening mucosal immune defense against intestinal pathogens such as Salmonella. In summary, the pathway ...

The microbiome not only consists of bacteria, but also of fungi. Most of them support human and animal health. However, some fungi also have pathogenic potential. For instance, the yeast Candida ...

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

Norovirus conjures a nightmarish series of gastrointestinal symptoms, and the hated infection has been rampant this winter. The so-called stomach flu—although it’s unrelated to influenza—strikes ...

NORTH CHICAGO, Ill.--(BUSINESS WIRE)--32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that ...